METABOLIC BRAIN DISEASE

Scope & Guideline

Pioneering research in metabolic brain disorders.

Introduction

Welcome to your portal for understanding METABOLIC BRAIN DISEASE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0885-7490
PublisherSPRINGER/PLENUM PUBLISHERS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1986 to 2024
AbbreviationMETAB BRAIN DIS / Metab. Brain Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address233 SPRING ST, NEW YORK, NY 10013

Aims and Scopes

The journal 'Metabolic Brain Disease' focuses on the interplay between metabolic processes and neurological health, exploring how metabolic dysfunctions can lead to brain diseases. It aims to disseminate research findings that connect metabolic pathways with neurodegenerative and psychiatric disorders, employing a variety of methodologies including molecular biology, biochemistry, and clinical studies.
  1. Metabolic Dysfunction and Neurological Disorders:
    The journal emphasizes research on how metabolic disorders, such as diabetes and obesity, contribute to the pathogenesis of various neurological diseases, including Alzheimer's, Parkinson's, and multiple sclerosis.
  2. Neuroinflammation and Oxidative Stress:
    It explores the role of neuroinflammation and oxidative stress in brain disorders, focusing on their contributions to neuronal damage and cognitive decline.
  3. Therapeutic Approaches and Drug Development:
    Research on novel pharmacological and non-pharmacological interventions, including natural compounds and lifestyle modifications, aimed at mitigating metabolic and neurological disorders is a core focus.
  4. Molecular and Genetic Mechanisms:
    The journal publishes studies that investigate the molecular and genetic underpinnings of brain diseases, including the role of non-coding RNAs and metabolic enzymes.
  5. Animal Models and Clinical Studies:
    Utilizing both experimental animal models and clinical studies, the journal aims to bridge the gap between laboratory research and therapeutic applications in humans.
Recent publications in 'Metabolic Brain Disease' demonstrate a clear evolution in research themes, highlighting emerging trends that are becoming increasingly relevant in the context of neurological health and metabolic interactions.
  1. Gut-Brain Axis Research:
    An increasing number of studies are investigating the gut-brain connection, particularly how gut microbiota and metabolites influence neurological disorders and cognitive functions.
  2. Network Pharmacology and Integrative Approaches:
    The use of network pharmacology and integrative approaches to drug discovery is on the rise, reflecting a shift towards understanding the multi-target effects of therapies rather than focusing on single molecules.
  3. Neuroprotective Natural Compounds:
    There is a growing interest in the neuroprotective properties of natural compounds, with many studies exploring how dietary components and herbal extracts can prevent or mitigate brain disorders.
  4. MicroRNA and Epigenetics:
    Research focusing on the role of microRNAs and epigenetic modifications in metabolic and neurological diseases is trending, emphasizing their potential as biomarkers and therapeutic targets.
  5. Exercise and Lifestyle Interventions:
    An emerging focus on the effects of physical activity and lifestyle changes on brain health is evident, with studies documenting how exercise can influence cognitive function and metabolic health.

Declining or Waning

While 'Metabolic Brain Disease' continues to expand into new areas of research, some traditional themes are showing signs of decline. These waning scopes reflect shifts in research priorities and emerging interests in the field.
  1. Traditional Drug Development Approaches:
    There is a noticeable decrease in publications focusing solely on conventional pharmacological approaches, as research shifts towards integrative and holistic treatment strategies.
  2. Basic Neuroanatomy Studies:
    Research that primarily focuses on basic neuroanatomical studies without linking to metabolic or pathological conditions has become less prominent, indicating a shift towards more clinically relevant investigations.
  3. Single-Factor Studies:
    Studies examining single metabolic factors in isolation are declining, as there is a growing preference for comprehensive, multi-factorial approaches that consider the interplay of various metabolic and neurological factors.

Similar Journals

REDOX REPORT

Fostering Dialogue in Life Sciences Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1351-0002Frequency: 1 issue/year

REDOX REPORT is a peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the latest advancements in the fields of biochemistry, clinical biochemistry, and physiology. Since its inception in 1996 and transitioning to an Open Access model in 2018, this journal has aimed to disseminate high-quality research findings and foster discussions within the scientific community. Positioned in the Q2 quartile across several relevant categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, REDOX REPORT is recognized for its commitment to impactful research. The journal plays a crucial role in bridging the gap between fundamental biochemical research and its clinical applications, making it an essential resource for researchers, professionals, and students alike. With a consistent publication record extending to 2024, REDOX REPORT is dedicated to featuring cutting-edge studies that advance our understanding of redox biology, thereby contributing significantly to the ongoing dialogue in the life sciences.

BRAIN RESEARCH

Fostering breakthroughs in developmental and molecular biology.
Publisher: ELSEVIERISSN: 0006-8993Frequency: 24 issues/year

BRAIN RESEARCH is a premier journal published by Elsevier, specializing in the intricate domains of neuroscience, developmental biology, and molecular biology. Established in 1966, this esteemed publication has become a cornerstone for researchers, professionals, and students dedicated to advancing our understanding of brain function and disorders. With an impressive impact factor and a consistent presence in the Q2 quartiles across key categories—such as Developmental Biology, Neurology, and Neuroscience—it stands out as an essential resource for disseminating innovative research and pioneering insights. The journal's scope encompasses both clinical and fundamental studies, fostering a multidisciplinary approach to the complexities of neural systems. Although it is not an open-access journal, BRAIN RESEARCH provides a vital platform for sharing progressive findings that can inspire future studies and contribute significantly to the evolutionary discourse in neuroscience. Based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, BRAIN RESEARCH continues to shape the landscape of neuroscience research, inviting submissions that explore the latest discoveries and therapeutic strategies.

Archives of Endocrinology Metabolism

Advancing knowledge in endocrinology and metabolism.
Publisher: SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIAISSN: 2359-3997Frequency: 6 issues/year

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

NEUROCHEMISTRY INTERNATIONAL

Driving Progress in Neuroscience Through Rigorous Research
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

BRAIN BEHAVIOR AND IMMUNITY

Connecting Minds: Where Neuroscience Meets Immunology.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0889-1591Frequency: 8 issues/year

BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY

Pioneering Reviews for Tomorrow's Discoveries
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-9238Frequency: 6 issues/year

Welcome to Critical Reviews in Biochemistry and Molecular Biology, a premier academic journal published by Taylor & Francis Ltd, dedicated to advancing the fields of biochemistry and molecular biology. With an impressive impact factor and a Q1 ranking in both Biochemistry and Molecular Biology for 2023, this journal serves as a vital resource for researchers, professionals, and students eager to engage with cutting-edge reviews and analyses that synthesize the latest developments in these dynamic areas of study. Since its inception in 1972, the journal has maintained a commitment to high-quality scholarship, providing a platform for critical discussions that accelerate the discovery and understanding of biochemical processes and molecular interactions. Although not open access, its robust editorial peer-review process ensures that published articles meet the highest standards of scientific rigor, making it a trusted source for the scientific community. As we continue to converge toward 2024, we invite you to explore the extensive array of topics and findings that have shaped contemporary biochemistry and molecular biology.

JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

Connecting Science and Medicine through Trace Element Research
Publisher: ELSEVIER GMBHISSN: 0946-672XFrequency: 6 issues/year

The JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, published by Elsevier GmbH, stands as a leading platform for disseminating pivotal research in the interdisciplinary field that bridges biochemistry, inorganic chemistry, and molecular medicine. With an impact factor reflective of its high-quality submissions and significant contribution to the scientific community, this journal currently holds a Q2 ranking in Biochemistry and a Q1 ranking in Inorganic Chemistry, underlining its esteemed status among peers. Since its inception in 1995 and continuing through to 2024, the journal has fostered a dynamic discourse on the fundamental roles of trace elements in biological systems, incorporating studies that range from their biochemical functions to their impact on health and disease. Researchers, professionals, and students alike can access a wealth of knowledge, missing Open Access options notwithstanding, making it indispensable for those at the forefront of scientific investigation in medicine and biology.

NEUROSCIENCE RESEARCH

Exploring the Depths of Neuroscience Innovation
Publisher: ELSEVIER IRELAND LTDISSN: 0168-0102Frequency: 12 issues/year

NEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.

Egyptian Journal of Neurology Psychiatry and Neurosurgery

Advancing Knowledge in Neurology, Psychiatry, and Neurosurgery
Publisher: SPRINGERISSN: 1687-8329Frequency: 1 issue/year

Egyptian Journal of Neurology Psychiatry and Neurosurgery, published by Springer, is a premier open-access journal that has been dedicated to advancing the fields of neurology, psychiatry, and neurosurgery since its inception in 2009. With an E-ISSN of 1687-8329, this journal aims to provide a dynamic platform for researchers and clinicians to disseminate their findings, fostering a rich dialogue on the latest developments and innovations within these critical disciplines. With an impactful open-access model adopted since 2018, the journal attracts a global audience, facilitating the exchange of knowledge and ideas across various medical and scientific landscapes. In the 2023 rankings, it holds impressive positions within the Q3 category for Neurology (clinical), Psychiatry and Mental Health, and Surgery, as well as Q4 in Miscellaneous Neuroscience, highlighting its value within the field. As a valuable resource for both budding scholars and seasoned professionals, the Egyptian Journal of Neurology Psychiatry and Neurosurgery offers insights that drive progress in the treatment and understanding of neurological and psychiatric conditions.

HORMONE AND METABOLIC RESEARCH

Decoding Metabolic Pathways Through Hormonal Research
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.